179 related articles for article (PubMed ID: 30551857)
1. The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer.
Jeene PM; van Laarhoven HWM; Hulshof MCCM
Best Pract Res Clin Gastroenterol; 2018; 36-37():53-59. PubMed ID: 30551857
[TBL] [Abstract][Full Text] [Related]
2. Definitive chemoradiation for locoregional recurrences of esophageal cancer after primary curative treatment.
Jeene PM; Versteijne E; van Berge Henegouwen MI; Bergmann JJ; Geijsen ED; Muller K; van Laarhoven HW; Hulshof MC
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27766725
[TBL] [Abstract][Full Text] [Related]
3. Randomized Study on Dose Escalation in Definitive Chemoradiation for Patients With Locally Advanced Esophageal Cancer (ARTDECO Study).
Hulshof MCCM; Geijsen ED; Rozema T; Oppedijk V; Buijsen J; Neelis KJ; Nuyttens JJME; van der Sangen MJC; Jeene PM; Reinders JG; van Berge Henegouwen MI; Thano A; van Hooft JE; van Laarhoven HWM; van der Gaast A
J Clin Oncol; 2021 Sep; 39(25):2816-2824. PubMed ID: 34101496
[TBL] [Abstract][Full Text] [Related]
4. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
5. Outcome of Weekly Carboplatin-Paclitaxel-based Definitive Chemoradiation in Oesophageal Cancer in Patients Not Considered to be Suitable for Platinum-Fluoropyrimidine-based Treatment: A Multicentre, Retrospective Review.
Owens R; Cox C; Gomberg S; Pan S; Radhakrishna G; Parikh S; Goody R; Hingorani M; Prince S; Bird T; Dorey N; Macgregor U; Al-Chamali H; Hurt C; Mukherjee S
Clin Oncol (R Coll Radiol); 2020 Feb; 32(2):121-130. PubMed ID: 31662220
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for esophageal fistula in thoracic esophageal squamous cell carcinoma invading adjacent organs treated with definitive chemoradiotherapy: a monocentric case-control study.
Kawakami T; Tsushima T; Omae K; Ogawa H; Shirasu H; Kito Y; Yoshida Y; Hamauchi S; Todaka A; Machida N; Yokota T; Yamazaki K; Fukutomi A; Onozawa Y; Yasui H
BMC Cancer; 2018 May; 18(1):573. PubMed ID: 29776344
[TBL] [Abstract][Full Text] [Related]
7. Definitive chemoradiation for patients with inoperable and/or unresectable esophageal cancer: locoregional recurrence pattern.
Versteijne E; van Laarhoven HW; van Hooft JE; van Os RM; Geijsen ED; van Berge Henegouwen MI; Hulshof MC
Dis Esophagus; 2015 Jul; 28(5):453-9. PubMed ID: 24725186
[TBL] [Abstract][Full Text] [Related]
8. Survival after definitive (chemo)radiotherapy in esophageal cancer patients: a population-based study in the north-East Netherlands.
Smit JK; Muijs CT; Burgerhof JG; Paardekooper G; Timmer PR; Muller K; Woutersen D; Mul VE; Beukema JC; Hospers GA; van Dijk BA; Langendijk JA; Plukker JT
Ann Surg Oncol; 2013 Jun; 20(6):1985-92. PubMed ID: 23274534
[TBL] [Abstract][Full Text] [Related]
9. The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial.
Brenner B; Purim O; Gordon N; Goshen-Lago T; Idelevich E; Kashtan H; Menasherov N; Fenig E; Sulkes A; Kundel Y
Radiother Oncol; 2019 May; 134():74-80. PubMed ID: 31005227
[TBL] [Abstract][Full Text] [Related]
10. A phase II study of concurrent chemoradiotherapy combined with a weekly paclitaxel and 5-fluorouracil regimen to treat patients with advanced oesophageal carcinoma.
Xia Y; Li YH; Chen Y; Zhang JH; Liu Q; Deng JY; Ai TS; Zhu HT; Fan JH; Badakhshi H; Zhao KL
Radiat Oncol; 2017 Mar; 12(1):47. PubMed ID: 28270162
[TBL] [Abstract][Full Text] [Related]
11. Patterns of recurrence following definitive chemoradiation for patients with proximal esophageal cancer.
de Vos-Geelen J; Geurts SME; Nieuwenhuijzen GAP; Voncken FEM; Bogers JA; Braam PM; Muijs CT; de Jong MA; Kasperts N; Rozema T; Blom GJ; Bouwense SAW; Valkenburg-van Iersel LBJ; Jeene PM; Hoebers FJP; Tjan-Heijnen VCG
Eur J Surg Oncol; 2021 Aug; 47(8):2016-2022. PubMed ID: 33583629
[TBL] [Abstract][Full Text] [Related]
12. Assessing failure patterns of radical intent radiation strategies in patients with locally advanced carcinoma of the esophagus.
Mishra S; Ahmad F; Singh S; Singh RK; Das KJM; Kumar S
Cancer Rep (Hoboken); 2021 Jun; 4(3):e1332. PubMed ID: 33369258
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus.
Gkika E; Gauler T; Eberhardt W; Stahl M; Stuschke M; Pöttgen C
Dis Esophagus; 2014; 27(7):678-84. PubMed ID: 24147973
[TBL] [Abstract][Full Text] [Related]
14. Survival after neoadjuvant chemoradiotherapy and oesophagectomy versus definitive chemoradiotherapy for patients with oesophageal squamous cell carcinoma.
Wang BY; Wu SC; Chen HC; Hung WH; Lin CH; Huang CL; Chen HS
Br J Surg; 2019 Feb; 106(3):255-262. PubMed ID: 30395362
[TBL] [Abstract][Full Text] [Related]
15. Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma?
Gamboa AC; Meyer BI; Switchenko JM; Rupji M; Lee RM; Turgeon MK; Russell MC; Cardona K; Kooby DA; Maithel SK; Shah MM
J Surg Oncol; 2020 Sep; 122(3):412-421. PubMed ID: 32462769
[TBL] [Abstract][Full Text] [Related]
16. Chemoradiation in oesophageal cancer.
Dai T; Shah MA
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):193-209. PubMed ID: 25743466
[TBL] [Abstract][Full Text] [Related]
17. Endostatin and Oxaliplatin-Based Chemoradiotherapy for Inoperable Esophageal Squamous Cell Carcinoma: Results of a Phase II Study.
Li W; Chen P; Zhang N; Song T; Wu S
Oncologist; 2019 Apr; 24(4):461-e136. PubMed ID: 30850562
[TBL] [Abstract][Full Text] [Related]
18. Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study.
Kordes S; van Berge Henegouwen MI; Hulshof MC; Bergman JJ; van der Vliet HJ; Kapiteijn E; van Laarhoven HW; Richel DJ; Klinkenbijl JH; Meijer SL; Wilmink JW
Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):190-6. PubMed ID: 25195993
[TBL] [Abstract][Full Text] [Related]
19. Tolerability and efficacy of concurrent chemoradiotherapy comparing carboplatin/paclitaxel versus platinum/5-FU regimen for locally advanced esophageal and esophagogastric junction cancers.
Tamtai A; Jiarpinitnun C; Hiranyatheb P; Unwanatham N; Sirachainun E; Supsamutchai C; Pattaranutaporn P; Ngamphaiboon N
Med Oncol; 2017 Sep; 34(9):157. PubMed ID: 28785986
[TBL] [Abstract][Full Text] [Related]
20. Definitive chemoradiation or surgery in elderly patients with potentially curable esophageal cancer in the Netherlands: a nationwide population-based study on patterns of care and survival.
Koëter M; van Putten M; Verhoeven RHA; Lemmens VEPP; Nieuwenhuijzen GAP
Acta Oncol; 2018 Sep; 57(9):1192-1200. PubMed ID: 29528262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
